Literature DB >> 17601930

De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features.

Oddmund Søvik1, Suzanne Schubbert, Gunnar Houge, Solrun J Steine, Gunnar Norgård, Bernt Engelsen, Pål R Njølstad, Kevin Shannon, Anders Molven.   

Abstract

Mutations in genes involved in Ras signalling cause Noonan syndrome and other disorders characterised by growth disturbances and variable neuro-cardio-facio-cutaneous features. We describe two sisters, 46 and 31 years old, who presented with dysmorphic features, hypotonia, feeding difficulties, retarded growth and psychomotor retardation early in life. The patients were initially diagnosed with Costello syndrome, and autosomal recessive inheritance was assumed. Remarkably, however, we identified a germline HRAS mutation (G12A) in one sister and a germline KRAS mutation (F156L) in her sibling. Both mutations had arisen de novo. The F156L mutant K-Ras protein accumulated in the active, guanosine triphosphate-bound conformation and affected downstream signalling. The patient harbouring this mutation was followed for three decades, and her cardiac hypertrophy gradually normalised. However, she developed severe epilepsy with hippocampal sclerosis and atrophy. The occurrence of distinct de novo mutations adds to variable expressivity and gonadal mosaicism as possible explanations of how an autosomal dominant disease may manifest as an apparently recessive condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17601930      PMCID: PMC2598016          DOI: 10.1136/jmg.2007.049361

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  40 in total

Review 1.  The origins, patterns and implications of human spontaneous mutation.

Authors:  J F Crow
Journal:  Nat Rev Genet       Date:  2000-10       Impact factor: 53.242

2.  Protein kinase modulation of dendritic K+ channels in hippocampus involves a mitogen-activated protein kinase pathway.

Authors:  Li-Lian Yuan; J Paige Adams; Michael Swank; J David Sweatt; Daniel Johnston
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

3.  H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.

Authors:  A Sakamoto; Y Oda; T Adachi; Y Oshiro; S Tamiya; K Tanaka; S Matsuda; Y Iwamoto; M Tsuneyoshi
Journal:  Mod Pathol       Date:  2001-04       Impact factor: 7.842

4.  Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations.

Authors:  Martin Zenker; Katarina Lehmann; Anna Leana Schulz; Helmut Barth; Dagmar Hansmann; Rainer Koenig; Rudolf Korinthenberg; Martina Kreiss-Nachtsheim; Peter Meinecke; Susanne Morlot; Stefan Mundlos; Anne S Quante; Salmo Raskin; Dirk Schnabel; Lars-Erik Wehner; Christian P Kratz; Denise Horn; Kerstin Kutsche
Journal:  J Med Genet       Date:  2006-10-20       Impact factor: 6.318

5.  Neurologic and gastrointestinal dysfunction in cardio-facio-cutaneous syndrome: identification of a severe phenotype.

Authors:  T A Grebe; C Clericuzio
Journal:  Am J Med Genet       Date:  2000-11-13

6.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.

Authors:  M Tartaglia; E L Mehler; R Goldberg; G Zampino; H G Brunner; H Kremer; I van der Burgt; A H Crosby; A Ion; S Jeffery; K Kalidas; M A Patton; R S Kucherlapati; B D Gelb
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

7.  PTPN11 mutations in LEOPARD syndrome.

Authors:  E Legius; C Schrander-Stumpel; E Schollen; C Pulles-Heintzberger; M Gewillig; J-P Fryns
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

8.  Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line.

Authors:  Anne Goriely; Gilean A T McVean; Maria Röjmyr; Björn Ingemarsson; Andrew O M Wilkie
Journal:  Science       Date:  2003-08-01       Impact factor: 47.728

9.  Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.

Authors:  Maria Cristina Digilio; Emanuela Conti; Anna Sarkozy; Rita Mingarelli; Tania Dottorini; Bruno Marino; Antonio Pizzuti; Bruno Dallapiccola
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

10.  The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm.

Authors:  Rivka L Glaser; Karl W Broman; Rebecca L Schulman; Brenda Eskenazi; Andrew J Wyrobek; Ethylin Wang Jabs
Journal:  Am J Hum Genet       Date:  2003-07-31       Impact factor: 11.025

View more
  11 in total

1.  Molecular confirmation of HRAS p.G12S in siblings with Costello syndrome.

Authors:  Karen W Gripp; Deborah L Stabley; Peter L Geller; Elizabeth Hopkins; David A Stevenson; John C Carey; Katia Sol-Church
Journal:  Am J Med Genet A       Date:  2011-08-10       Impact factor: 2.802

2.  Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework.

Authors:  Andrew R Grant; Brandon J Cushman; Hélène Cavé; Mitchell W Dillon; Bruce D Gelb; Karen W Gripp; Jennifer A Lee; Heather Mason-Suares; Katherine A Rauen; Marco Tartaglia; Lisa M Vincent; Martin Zenker
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

Review 3.  Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease.

Authors:  Anne Goriely; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2012-02-10       Impact factor: 11.025

4.  Biochemical and functional characterization of germ line KRAS mutations.

Authors:  Suzanne Schubbert; Gideon Bollag; Natalya Lyubynska; Hoa Nguyen; Christian P Kratz; Martin Zenker; Charlotte M Niemeyer; Anders Molven; Kevin Shannon
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

Review 5.  Noonan syndrome caused by germline KRAS mutation in Taiwan: report of two patients and a review of the literature.

Authors:  Fu-Sung Lo; Ju-Li Lin; Min-Tzu Kuo; Pao-Chin Chiu; San-Ging Shu; Mei-Chyn Chao; Yann-Jinn Lee; Shuan-Pei Lin
Journal:  Eur J Pediatr       Date:  2008-10-29       Impact factor: 3.183

6.  A conserved phenylalanine as a relay between the α5 helix and the GDP binding region of heterotrimeric Gi protein α subunit.

Authors:  Ali I Kaya; Alyssa D Lokits; James A Gilbert; Tina M Iverson; Jens Meiler; Heidi E Hamm
Journal:  J Biol Chem       Date:  2014-07-18       Impact factor: 5.157

7.  A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive condition.

Authors:  Alberto J Schuhmacher; Carmen Guerra; Vincent Sauzeau; Marta Cañamero; Xosé R Bustelo; Mariano Barbacid
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

8.  BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors.

Authors:  Kimberly Brown Dahlman; Junfeng Xia; Katherine Hutchinson; Charles Ng; Donald Hucks; Peilin Jia; Mohammad Atefi; Zengliu Su; Suzanne Branch; Pamela L Lyle; Donna J Hicks; Viviana Bozon; John A Glaspy; Neal Rosen; David B Solit; James L Netterville; Cindy L Vnencak-Jones; Jeffrey A Sosman; Antoni Ribas; Zhongming Zhao; William Pao
Journal:  Cancer Discov       Date:  2012-07-13       Impact factor: 39.397

Review 9.  Attention deficit hyperactivity disorder (ADHD) in phenotypically similar neurogenetic conditions: Turner syndrome and the RASopathies.

Authors:  Tamar Green; Paige E Naylor; William Davies
Journal:  J Neurodev Disord       Date:  2017-07-10       Impact factor: 4.025

Review 10.  Molecules linked to Ras signaling as therapeutic targets in cardiac pathologies.

Authors:  Manuel Ramos-Kuri; Sri Harika Meka; Fabio Salamanca-Buentello; Roger J Hajjar; Larissa Lipskaia; Elie R Chemaly
Journal:  Biol Res       Date:  2021-08-03       Impact factor: 5.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.